Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

for
Flexible Hammertoe, Semi-flexible Hammertoe
Location: Bedford TX, Fort Worth TX, Georgetown TX,
Sponsor: Endo USA Inc., a Keenova Therapeutics Company

Sex: All

Age: 18 - 70+

Code: NCT07759362

Phase 3, Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: North Richland Hills TX, DeSoto TX, McKinney TX,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting
Active & ResponsiveNew

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

for
Obesity, Overweight
Location: North Richland Hills TX, DeSoto TX, Dallas TX,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07871409

Phase 3, Recruiting
Active & Responsive

RA-PRO PRAGMATIC TRIAL

for
Rheumatoid Arthritis
Location: Colleyville TX, Dallas TX, Houston TX, Clovis NM,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04692493

Phase 3, Recruiting
Active & Responsive

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Colleyville TX, Mesquite TX, Plano TX, Baytown TX,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07290036

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for
Treatment-resistant Depression (TRD)
Location: Irving TX, Fort Worth TX, Dallas TX, Plano TX,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70+

Code: NCT07553637

Phase 2, Recruiting
Active & Responsive

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

for
Moderate to Severe Psoriatic Arthritis
Location: Colleyville TX, Katy TX, San Antonio TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07801495

Phase 2, Recruiting
Active & Responsive

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

for
Sjögren´s Disease
Location: Euless TX, Leander TX, Oklahoma City OK, Houston TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07621809

Phase 3, Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Euless TX, Irving TX, Dallas TX, Fort Worth TX,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

for
Rheumatoid Arthritis
Location: Colleyville TX, Tomball TX, Lake Charles LA, Houston TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07137598

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Irving TX, DeSoto TX, Austin TX, Oklahoma City OK,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase 3, Recruiting
Active & Responsive

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

for
Overweight , Obesity, Adults
Location: Irving TX, Oklahoma City OK, Tomball TX, San Antonio TX,
Sponsor: Alveus Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07837973

Phase 2, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Mansfield TX, Fort Worth TX, Lewisville TX, Dallas TX,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

for
Bipolar Disorder Type I With Mania
Location: Mansfield TX, DeSoto TX, Richardson TX, Austin TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06929273

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

for
Mania, Bipolar Disorder
Location: Mansfield TX, DeSoto TX, Richardson TX, Austin TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT07140913

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Fort Worth TX, Dallas TX, Forney TX, Denison TX,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Fort Worth TX, Oklahoma City OK, San Antonio TX,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for
Primary Immune Thrombocytopenia (ITP),
Location: Fort Worth TX, Fayetteville AR, Covington LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07421167

Phase 2, Recruiting
Active & Responsive

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Fort Worth TX, Dallas TX, Richardson TX,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting
Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for
Autoimmune Disease, Crohn Disease, Dermatomyositis,
Location: Fort Worth TX, Dallas TX, Richardson TX, Houston TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase 1, Recruiting